You Searched For "SII Vaccine makers" and got 20 results
Sort By:
1 min read
Chinese hackers target Indian vaccine makers SII and Bharat Biotech: Report
Both SII and Bharat Biotech are involved in producing Covid-19 vaccine. Moreover, Cyfirma add…
2 mins read
India’s vaccine king Adar Poonawalla will pay $69,000 a week to live on the same neighbourhood as Winston Churchill once did
Poonawalla, who is an alumnus of the University of Westminster, has often referred to London…
3 mins read
The success story of Cyrus Poonawalla: The vaccine king who is one of the world’s richest billionaires
India’s vaccine king tried to make an affordable Jaguar but chose to go for a ‘product of the masse…
2 mins read
Serum Institute's Covovax gets DCGI approval as a heterologous booster dose
"The Subject Expert Committee of the CDSCO on Wednesday deliberated on the issue and had recommende…
PTI
1 min read
SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adults
Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII had last week submitted an …
PTI
1 min read
SII expects nod for Covid-19 vaccine in 'few days'
New Delhi, Dec 28 (IANS) Pune-based Serum Institute of India on Monday expressed hope at the possib…
2 mins read
India requires Rs 80,000 cr for vaccine distribution next year: SII
New Delhi, Dec 19 (IANS) Pune-based vaccine-maker Serum Institute of India, which has partnered wit…
1 min read
Covishield maker Adar Poonawalla gets dose of his own vaccine
Pune, Jan 16 (IANS) In a huge confidence booster, Serum Institute of India's (SII) Chief Executive …
2 mins read
Sanofi, one of the largest drug makers, will test experimental coronavirus vaccine on humans starting September
The plan is to get thousands of subjects on board across the world to test the experimental c…
2 mins read
Serum Institute of India buys into IPO-bound insurance unicorn PolicyBazaar, as True North sells part stake in secondary sale
The investment firm True North (formerly India Value Fund) has sold a part of its stake in Polic…
2 mins read
WHO confirms existence of fake Covishield vaccines in India; Serum Institute pushes for a booster shot
SII makes India's primary COVID-19 vaccine, locally known as Covishield. Poonawalla also reve…
3 mins read
US-based biotechnology company Novavax’s COVID-19 shot is 90% effective
US-based biotechnology company Novavax's protein-based vaccine has shown overall 90 per cent effica…
2 mins read
COVID-19 vaccination for senior citizens to start from March 1 in India — will be free at government hospitals
The Indian government announced today that COVID-19 vaccine doses for senior citizens will be avail…
2 mins read
COVID vaccines may take up to 5 months to reach private centres — governments say slots for all adults may open only after 2-3 weeks
SII has also mentioned in its statement, “We would urge all corporate and private individuals …
5 mins read
If the COVID-19 vaccine prices are too high for some, then why not use direct benefit transfer
The new prices for COVID-19 vaccine, Covishield, has triggered a debate in India. Some argue that t…
4 mins read
India allows emergency use of Merck's new drug Molnupiravir for treatment of mild-to-moderate COVID-19 cases
An expert panel of the country's central drug authority has recommended granting emergency use auth…
PTI
3 mins read
Adar Poonawalla's Serum cuts Covishield vaccine price for state governments to ₹300 a dose after much backlash
In a tweet, Poonawalla called this cut a "philanthropic gesture" that will save crores of rupees…
1 min read
Central government asks Serum Institute and Bharat Biotech to lower price of COVID-19 vaccines, say official sources
Now the two companies are expected to come up with revised pricing for their vaccines. …
PTI
1 min read
COVID-19 vaccine: After Pfizer and Moderna, Serum Institute of India to seek indemnity protection
Covishield (local name of Oxford-Astrazeneca vaccine) is currently the most administered vaccine…
2 mins read
DCGI gives nod to Serum Institute of India for phase 2 and 3 human clinical trials of the Oxford COVID-19 vaccine candidate
"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the C…